Slate Path Capital LP - Nov 30, 2024 SCHEDULE 13G/A Report for Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN)

Filing Manager
Slate Path Capital LP
Reporting Manager
Slate Path Capital LP
Security
Cyclerion Therapeutics, Inc. Common Stock, no par value
Symbol
CYCN
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Date filed
12/6/2024, 04:05 PM
Date of event
Nov 30, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Slate Path Capital LP 0% 0 0 0 Jades GP, LLC, its General Partner, By: /s/ John Metzner John Metzner, Chief Operating Officer
David Greenspan 0% 0 0 0 /s/ Jim Feeney Jim Feeney, Attorney-In-Fact*